Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker LLY
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Anat Hakim EVP, GC & Secretary | LLY Eli Lilly and Company | Sale | 5,000 | $1,402.52 | $7.0M Sale | Form 4 ↗ |
| Aug 17, 2026 | Patrik Jonsson EVP & President, LLY Int'l | LLY Eli Lilly and Company | Sale | 6,500 | $1,175.10 | $7.6M Sale | Form 4 ↗ |
| Aug 10, 2026 | Donald A. Zakrowski SVP, Finance, & CAO | LLY Eli Lilly and Company | Sale | 2,000 | $1,185.01 | $2.4M Sale | Form 4 ↗ |
| Aug 7, 2026 | Anat Hakim EVP, GC & Secretary | LLY Eli Lilly and Company | Sale | 5,000 | $1,190.00 | $6.0M Sale | Form 4 ↗ |
| Jun 10, 2026 | Ilya Yuffa EVP&Pres, LLY USA&Global Capab | LLY Eli Lilly and Company | Sale | 2,500 | $1,150.77 | $2.9M Sale | Form 4 ↗ |
| May 6, 2026 | Lilly Endowment Inc | LLY Eli Lilly and Company | Sale | 2,208 | $996.18 | $2.2M Sale | Form 4 ↗ |
| May 6, 2026 | Lilly Endowment Inc | LLY Eli Lilly and Company | Sale | 13,620 | $995.23 | $13.6M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 2,737 | $1,116.69 | $3.1M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 2,210 | $1,115.76 | $2.5M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 4,342 | $1,114.37 | $4.8M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 9,053 | $1,113.77 | $10.1M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 4,652 | $1,112.43 | $5.2M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 2,085 | $1,111.21 | $2.3M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 3,464 | $1,110.37 | $3.8M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 8,513 | $1,109.32 | $9.4M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 13,247 | $1,108.42 | $14.7M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 16,650 | $1,107.37 | $18.4M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 13,701 | $1,106.42 | $15.2M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 24,362 | $1,105.46 | $26.9M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 21,042 | $1,104.40 | $23.2M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 40,956 | $1,103.31 | $45.2M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 34,434 | $1,102.41 | $38.0M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 20,668 | $1,101.42 | $22.8M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 14,937 | $1,100.46 | $16.4M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 20,447 | $1,099.36 | $22.5M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 9,573 | $1,098.55 | $10.5M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 6,408 | $1,097.41 | $7.0M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 475 | $1,095.74 | $520.5K Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 420 | $1,094.70 | $459.8K Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 1,322 | $1,093.58 | $1.4M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 1,072 | $1,092.56 | $1.2M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 1,224 | $1,091.05 | $1.3M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 3,575 | $1,090.18 | $3.9M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 930 | $1,088.97 | $1.0M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 1,070 | $1,087.80 | $1.2M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 7,684 | $1,086.75 | $8.4M Sale | Form 4 ↗ |
| Jan 7, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 895 | $1,085.11 | $971.2K Sale | Form 4 ↗ |
| Jan 5, 2026 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 1,390 | $1,085.01 | $1.5M Sale | Form 4 ↗ |
| Dec 29, 2025 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 3,593 | $1,085.04 | $3.9M Sale | Form 4 ↗ |
| Dec 24, 2025 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 2,629 | $1,085.17 | $2.9M Sale | Form 4 ↗ |
| Dec 23, 2025 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 240 | $1,085.04 | $260.4K Sale | Form 4 ↗ |
| Nov 25, 2025 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 1,340 | $1,110.53 | $1.5M Sale | Form 4 ↗ |
| Nov 25, 2025 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 9,249 | $1,109.45 | $10.3M Sale | Form 4 ↗ |
| Nov 25, 2025 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 5,043 | $1,108.71 | $5.6M Sale | Form 4 ↗ |
| Nov 25, 2025 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 7,794 | $1,107.48 | $8.6M Sale | Form 4 ↗ |
| Nov 25, 2025 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 3,662 | $1,106.57 | $4.1M Sale | Form 4 ↗ |
| Nov 25, 2025 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 2,494 | $1,105.32 | $2.8M Sale | Form 4 ↗ |
| Nov 25, 2025 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 5,196 | $1,104.41 | $5.7M Sale | Form 4 ↗ |
| Nov 25, 2025 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 6,274 | $1,103.58 | $6.9M Sale | Form 4 ↗ |
| Nov 25, 2025 | Lilly Endowment Inc 10% owner | LLY Eli Lilly and Company | Sale | 7,456 | $1,102.35 | $8.2M Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:22 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances